Alert

PGY2 Oncology

The University of North Carolina Medical Center (UNCMC) PGY2 oncology pharmacy residency prepares residents to become advanced practice providers and/or adjunct faculty at a college of pharmacy with expertise in oncology pharmacy. At UNCMC, the PGY2 oncology pharmacy residency serves to promote professionalism, the pursuit of scholarship, and provide learning experiences that prepare UNCMC oncology pharmacy residency graduates to assume positions in which they demonstrate leadership and compassion through work as highly skilled providers of care to oncology patients.

Overview of our Program

The University of North Carolina Medical Center (UNCMC) offers an American Society of Health-System Pharmacists (ASHP)-accredited post-graduate year 2 specialty residency in adult oncology pharmacy. The residency program aims to provide comprehensive training supported by advanced practice models in a variety of oncology care settings.

Our oncology pharmacy training program fosters a culture of innovation that supports opportunities for residents and encourages the development of practitioners who demonstrate the attributes of a leader.

Additionally, we promote an atmosphere of curiosity and one that encourages residents to engage in scholarly pursuits, fosters compassionate delivery of health care, and promotes preceptor development. Lastly, we aim to provide a collegial environment where residents feel supported through mentorship.

Collaboration with the North Carolina Comprehensive Cancer Center

The North Carolina Comprehensive Cancer Center, part of UNCMC, houses an interdisciplinary cancer care program in a 315,000-square foot building that was dedicated in 2009. The North Carolina Comprehensive Cancer Center is focused entirely on providing clinical care to patients with cancer.

Healthcare providers at the North Carolina Comprehensive Cancer Center treat patients from every county in North Carolina with more than 135,000 visits each year. It is a 50-bed facility (and growing) with many different oncology clinics that offer the opportunity to learn in a variety of practice settings.

Within the oncology service line, the Department of Pharmacy provides critical services to our patients in collaboration with interprofessional colleagues. We enjoy solid relationships with our interprofessional colleagues who value our contributions to care. Our oncology pharmacy practitioners provide a wide breadth of services in a diversity of practice settings that include both acute and ambulatory care.

At UNCMC, we nourish an advanced and innovative practice model in oncology pharmacy. Our oncology pharmacy team has won three American Society of Health-system Pharmacists Best Practice Awards. We continue to trail blaze, pushing the envelope with innovative pharmacy services supported by external funding resources. We believe the diversity in opportunities that you will encounter here are UNC will well-equip you with a confident mind and a strong skill set that readies you for success both now and in the future!

View our PGY2 Oncology Residency Brochure here


About the Residency Program Director

Dr. Auten is an acute care malignant hematology specialist at UNCMC and an Assistant Professor of Clinical Education at the UNC ESOP. She completed her undergraduate training at the University of North Carolina in Chapel Hill, NC and her Doctor of Pharmacy from the UNC Eshelman School of Pharmacy.

She completed a PGY1 pharmacy practice and PGY2 specialty residency in oncology pharmacy at Virginia Commonwealth University Health System in Richmond, VA. Dr. Auten’s practice and research interests focus on acute leukemia, supportive care, and patient education. She is the proud mother of Tyler Leigh (daughter), Simba (cat) and wife of Chad.

In her free time, Dr. Auten enjoys spending time with her family, hanging out on the water (ocean or lake), and enjoying great food with old and new friends!

For more information, contact:

Jessica Auten, PharmD, BCPS, BCOP
Residency Program Director, PGY2 Oncology
Clinical Pharmacy Specialist, Malignant Hematology
Top